AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFEPIME HYDROCHLORIDE
11 registrations across 4 African markets— 11 active
Markets with CEFEPIME HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| IVIPIME Dry powder for injection | 🇿🇲Zambia | VHB Medi Sciences Limited | active | Aug 2030 |
| IVIPIME Dry Powder for Injection | 🇷🇼Rwanda | VHB MEDI SCIENCES LIMITED | active | Feb 2030 |
| SEFIMAX POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS LTD | active | Dec 2028 |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | ARISTO PHARMACEUTICA LS PVT LTD | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | FAROMED LIFESCIENCES LLP | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
RETARD DRY VIALS | 🇺🇬Uganda | WORLD MEDICINE İLAÇ SAN. VE TIC. A.Ş. | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | ARISTO PHARMACEUTICA LS PVT LTD | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
RETARD DRY
VIALS | 🇺🇬Uganda | WORLD MEDICINE İLAÇ SAN. VE TIC. A.Ş. | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | FAROMED LIFESCIENCES LLP | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
RETARD DRY
VIALS | 🇺🇬Uganda | WORLD MEDICINE İLAÇ SAN. VE TIC. A.Ş. | active | — |
| CEFEPIME
HYDROCHLORIDE PARENTERAL
RETARD DRY VIALS | 🇺🇬Uganda | WORLD MEDICINE İLAÇ SAN. VE TIC. A.Ş. | active | — |
CEFEPIME HYDROCHLORIDE in Africa — Regulatory Overview
CEFEPIME HYDROCHLORIDE is registered across 4 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Rwanda, Zambia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.